nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP3A4—type 2 diabetes mellitus	0.129	0.534	CbGaD
Pethidine—ALB—type 2 diabetes mellitus	0.112	0.466	CbGaD
Pethidine—ORM1—Nateglinide—type 2 diabetes mellitus	0.0545	0.11	CbGbCtD
Pethidine—ALB—Gliclazide—type 2 diabetes mellitus	0.0356	0.0721	CbGbCtD
Pethidine—ALB—Repaglinide—type 2 diabetes mellitus	0.0335	0.0678	CbGbCtD
Pethidine—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0279	0.0566	CbGbCtD
Pethidine—ALB—Valsartan—type 2 diabetes mellitus	0.0247	0.05	CbGbCtD
Pethidine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0231	0.0468	CbGbCtD
Pethidine—ALB—Nateglinide—type 2 diabetes mellitus	0.0229	0.0465	CbGbCtD
Pethidine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0196	0.0398	CbGbCtD
Pethidine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0196	0.0398	CbGbCtD
Pethidine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0181	0.0367	CbGbCtD
Pethidine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0175	0.0354	CbGbCtD
Pethidine—ALB—Glyburide—type 2 diabetes mellitus	0.0155	0.0314	CbGbCtD
Pethidine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0149	0.0302	CbGbCtD
Pethidine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0147	0.0298	CbGbCtD
Pethidine—ALB—Losartan—type 2 diabetes mellitus	0.0142	0.0287	CbGbCtD
Pethidine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0138	0.0279	CbGbCtD
Pethidine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0131	0.0266	CbGbCtD
Pethidine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.012	0.0243	CbGbCtD
Pethidine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0113	0.0229	CbGbCtD
Pethidine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0108	0.022	CbGbCtD
Pethidine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0105	0.0213	CbGbCtD
Pethidine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.01	0.0204	CbGbCtD
Pethidine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00948	0.0192	CbGbCtD
Pethidine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00918	0.0186	CbGbCtD
Pethidine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00719	0.0146	CbGbCtD
Pethidine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00689	0.014	CbGbCtD
Pethidine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00689	0.014	CbGbCtD
Pethidine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00651	0.0132	CbGbCtD
Pethidine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00485	0.00984	CbGbCtD
Pethidine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00444	0.009	CbGbCtD
Pethidine—GRIN2C—nerve—type 2 diabetes mellitus	0.00334	0.177	CbGeAlD
Pethidine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00272	0.144	CbGeAlD
Pethidine—GRIN2B—nerve—type 2 diabetes mellitus	0.00264	0.14	CbGeAlD
Pethidine—GRIN2A—nerve—type 2 diabetes mellitus	0.00231	0.122	CbGeAlD
Pethidine—Etomidate—SLC2A1—type 2 diabetes mellitus	0.00226	0.604	CrCbGaD
Pethidine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00183	0.0965	CbGeAlD
Pethidine—OPRM1—nerve—type 2 diabetes mellitus	0.0014	0.0742	CbGeAlD
Pethidine—SLC6A3—nerve—type 2 diabetes mellitus	0.00127	0.0673	CbGeAlD
Pethidine—SLC6A2—nerve—type 2 diabetes mellitus	0.00103	0.0543	CbGeAlD
Pethidine—Glutethimide—CYP11A1—type 2 diabetes mellitus	0.000845	0.226	CrCbGaD
Pethidine—Ketobemidone—CYP3A4—type 2 diabetes mellitus	0.000375	0.1	CrCbGaD
Pethidine—ORM1—liver—type 2 diabetes mellitus	0.000297	0.0157	CbGeAlD
Pethidine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000295	0.0156	CbGeAlD
Pethidine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000265	0.014	CbGeAlD
Pethidine—Levomilnacipran—CYP3A4—type 2 diabetes mellitus	0.000264	0.0705	CrCbGaD
Pethidine—ALB—liver—type 2 diabetes mellitus	0.00026	0.0138	CbGeAlD
Pethidine—CYP2B6—kidney—type 2 diabetes mellitus	0.000259	0.0137	CbGeAlD
Pethidine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000226	0.00166	CcSEcCtD
Pethidine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000226	0.00165	CcSEcCtD
Pethidine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000226	0.00165	CcSEcCtD
Pethidine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000226	0.00165	CcSEcCtD
Pethidine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000226	0.00165	CcSEcCtD
Pethidine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000225	0.00165	CcSEcCtD
Pethidine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000225	0.00165	CcSEcCtD
Pethidine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000225	0.00165	CcSEcCtD
Pethidine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000224	0.00164	CcSEcCtD
Pethidine—Erythema—Metformin—type 2 diabetes mellitus	0.000222	0.00163	CcSEcCtD
Pethidine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000222	0.00163	CcSEcCtD
Pethidine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000222	0.00162	CcSEcCtD
Pethidine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000221	0.00162	CcSEcCtD
Pethidine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000219	0.00161	CcSEcCtD
Pethidine—Syncope—Valsartan—type 2 diabetes mellitus	0.000219	0.0016	CcSEcCtD
Pethidine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000219	0.0016	CcSEcCtD
Pethidine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00159	CcSEcCtD
Pethidine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000217	0.00159	CcSEcCtD
Pethidine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000216	0.00158	CcSEcCtD
Pethidine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000216	0.00158	CcSEcCtD
Pethidine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000216	0.00158	CcSEcCtD
Pethidine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000215	0.00158	CcSEcCtD
Pethidine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000215	0.00157	CcSEcCtD
Pethidine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000214	0.00157	CcSEcCtD
Pethidine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000213	0.00156	CcSEcCtD
Pethidine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000213	0.00156	CcSEcCtD
Pethidine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000212	0.00155	CcSEcCtD
Pethidine—Flushing—Losartan—type 2 diabetes mellitus	0.000211	0.00154	CcSEcCtD
Pethidine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00021	0.00154	CcSEcCtD
Pethidine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00021	0.00154	CcSEcCtD
Pethidine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00154	CcSEcCtD
Pethidine—Erythema—Irbesartan—type 2 diabetes mellitus	0.00021	0.00154	CcSEcCtD
Pethidine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00021	0.00154	CcSEcCtD
Pethidine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00021	0.00153	CcSEcCtD
Pethidine—CYP2C19—liver—type 2 diabetes mellitus	0.000209	0.0111	CbGeAlD
Pethidine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000209	0.00153	CcSEcCtD
Pethidine—Tremor—Metformin—type 2 diabetes mellitus	0.000208	0.00153	CcSEcCtD
Pethidine—Sweating—Ramipril—type 2 diabetes mellitus	0.000208	0.00152	CcSEcCtD
Pethidine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000208	0.00152	CcSEcCtD
Pethidine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000207	0.00152	CcSEcCtD
Pethidine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000207	0.00152	CcSEcCtD
Pethidine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000205	0.0015	CcSEcCtD
Pethidine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000203	0.00149	CcSEcCtD
Pethidine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000203	0.00148	CcSEcCtD
Pethidine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000202	0.00148	CcSEcCtD
Pethidine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000201	0.00147	CcSEcCtD
Pethidine—Vomiting—Glipizide—type 2 diabetes mellitus	0.0002	0.00146	CcSEcCtD
Pethidine—Syncope—Metformin—type 2 diabetes mellitus	0.000199	0.00146	CcSEcCtD
Pethidine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000199	0.00146	CcSEcCtD
Pethidine—Oedema—Valsartan—type 2 diabetes mellitus	0.000199	0.00146	CcSEcCtD
Pethidine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000199	0.00146	CcSEcCtD
Pethidine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000199	0.00146	CcSEcCtD
Pethidine—Rash—Glipizide—type 2 diabetes mellitus	0.000198	0.00145	CcSEcCtD
Pethidine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000198	0.00145	CcSEcCtD
Pethidine—Erythema—Losartan—type 2 diabetes mellitus	0.000198	0.00145	CcSEcCtD
Pethidine—Oedema—Orlistat—type 2 diabetes mellitus	0.000197	0.00144	CcSEcCtD
Pethidine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000197	0.00144	CcSEcCtD
Pethidine—Headache—Glipizide—type 2 diabetes mellitus	0.000197	0.00144	CcSEcCtD
Pethidine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000197	0.00144	CcSEcCtD
Pethidine—Palpitations—Metformin—type 2 diabetes mellitus	0.000197	0.00144	CcSEcCtD
Pethidine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000196	0.00144	CcSEcCtD
Pethidine—Shock—Valsartan—type 2 diabetes mellitus	0.000196	0.00144	CcSEcCtD
Pethidine—CYP3A4—kidney—type 2 diabetes mellitus	0.000196	0.0104	CbGeAlD
Pethidine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000195	0.00143	CcSEcCtD
Pethidine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000194	0.00142	CcSEcCtD
Pethidine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000193	0.00141	CcSEcCtD
Pethidine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000193	0.00141	CcSEcCtD
Pethidine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000193	0.00141	CcSEcCtD
Pethidine—CYP2D6—kidney—type 2 diabetes mellitus	0.000193	0.0102	CbGeAlD
Pethidine—Hypertension—Metformin—type 2 diabetes mellitus	0.000192	0.00141	CcSEcCtD
Pethidine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000192	0.00141	CcSEcCtD
Pethidine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00019	0.00139	CcSEcCtD
Pethidine—Anorexia—Valsartan—type 2 diabetes mellitus	0.00019	0.00139	CcSEcCtD
Pethidine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00019	0.00139	CcSEcCtD
Pethidine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00019	0.00139	CcSEcCtD
Pethidine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000189	0.00138	CcSEcCtD
Pethidine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000188	0.00138	CcSEcCtD
Pethidine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000188	0.00138	CcSEcCtD
Pethidine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000187	0.00137	CcSEcCtD
Pethidine—Nausea—Glipizide—type 2 diabetes mellitus	0.000186	0.00137	CcSEcCtD
Pethidine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000186	0.00136	CcSEcCtD
Pethidine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000186	0.00136	CcSEcCtD
Pethidine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000186	0.00136	CcSEcCtD
Pethidine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000186	0.00136	CcSEcCtD
Pethidine—Tremor—Losartan—type 2 diabetes mellitus	0.000185	0.00136	CcSEcCtD
Pethidine—Rash—Glimepiride—type 2 diabetes mellitus	0.000185	0.00135	CcSEcCtD
Pethidine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000185	0.00135	CcSEcCtD
Pethidine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000184	0.00135	CcSEcCtD
Pethidine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000184	0.00135	CcSEcCtD
Pethidine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000184	0.00135	CcSEcCtD
Pethidine—Headache—Glimepiride—type 2 diabetes mellitus	0.000184	0.00134	CcSEcCtD
Pethidine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000183	0.00134	CcSEcCtD
Pethidine—Agitation—Losartan—type 2 diabetes mellitus	0.000182	0.00133	CcSEcCtD
Pethidine—Oedema—Metformin—type 2 diabetes mellitus	0.000182	0.00133	CcSEcCtD
Pethidine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000181	0.00133	CcSEcCtD
Pethidine—Flushing—Ramipril—type 2 diabetes mellitus	0.000181	0.00132	CcSEcCtD
Pethidine—Insomnia—Valsartan—type 2 diabetes mellitus	0.00018	0.00132	CcSEcCtD
Pethidine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000179	0.00131	CcSEcCtD
Pethidine—Shock—Metformin—type 2 diabetes mellitus	0.000179	0.00131	CcSEcCtD
Pethidine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000178	0.0013	CcSEcCtD
Pethidine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000178	0.0013	CcSEcCtD
Pethidine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000178	0.0013	CcSEcCtD
Pethidine—Vertigo—Losartan—type 2 diabetes mellitus	0.000177	0.0013	CcSEcCtD
Pethidine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000177	0.0013	CcSEcCtD
Pethidine—Syncope—Losartan—type 2 diabetes mellitus	0.000177	0.0013	CcSEcCtD
Pethidine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000175	0.00128	CcSEcCtD
Pethidine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000175	0.00128	CcSEcCtD
Pethidine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000175	0.00128	CcSEcCtD
Pethidine—Palpitations—Losartan—type 2 diabetes mellitus	0.000175	0.00128	CcSEcCtD
Pethidine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000174	0.00127	CcSEcCtD
Pethidine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000174	0.00127	CcSEcCtD
Pethidine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00127	CcSEcCtD
Pethidine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000173	0.00127	CcSEcCtD
Pethidine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000173	0.00127	CcSEcCtD
Pethidine—Anorexia—Metformin—type 2 diabetes mellitus	0.000173	0.00127	CcSEcCtD
Pethidine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000172	0.00126	CcSEcCtD
Pethidine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000171	0.00125	CcSEcCtD
Pethidine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000171	0.00125	CcSEcCtD
Pethidine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000171	0.00125	CcSEcCtD
Pethidine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000171	0.00125	CcSEcCtD
Pethidine—Constipation—Valsartan—type 2 diabetes mellitus	0.00017	0.00125	CcSEcCtD
Pethidine—Hypotension—Metformin—type 2 diabetes mellitus	0.00017	0.00124	CcSEcCtD
Pethidine—Erythema—Ramipril—type 2 diabetes mellitus	0.000169	0.00124	CcSEcCtD
Pethidine—Shock—Irbesartan—type 2 diabetes mellitus	0.000169	0.00123	CcSEcCtD
Pethidine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000168	0.00123	CcSEcCtD
Pethidine—Anxiety—Losartan—type 2 diabetes mellitus	0.000168	0.00123	CcSEcCtD
Pethidine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000167	0.00122	CcSEcCtD
Pethidine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00122	CcSEcCtD
Pethidine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00122	CcSEcCtD
Pethidine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000166	0.00121	CcSEcCtD
Pethidine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00121	CcSEcCtD
Pethidine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000164	0.0012	CcSEcCtD
Pethidine—CYP2B6—liver—type 2 diabetes mellitus	0.000164	0.00867	CbGeAlD
Pethidine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000163	0.0012	CcSEcCtD
Pethidine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000163	0.00119	CcSEcCtD
Pethidine—Confusional state—Losartan—type 2 diabetes mellitus	0.000163	0.00119	CcSEcCtD
Pethidine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000162	0.00119	CcSEcCtD
Pethidine—Somnolence—Metformin—type 2 diabetes mellitus	0.000161	0.00118	CcSEcCtD
Pethidine—Oedema—Losartan—type 2 diabetes mellitus	0.000161	0.00118	CcSEcCtD
Pethidine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000161	0.00118	CcSEcCtD
Pethidine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00016	0.00117	CcSEcCtD
Pethidine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00016	0.00117	CcSEcCtD
Pethidine—Tremor—Ramipril—type 2 diabetes mellitus	0.000159	0.00116	CcSEcCtD
Pethidine—Shock—Losartan—type 2 diabetes mellitus	0.000159	0.00116	CcSEcCtD
Pethidine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000158	0.00116	CcSEcCtD
Pethidine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000158	0.00116	CcSEcCtD
Pethidine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000157	0.00115	CcSEcCtD
Pethidine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00115	CcSEcCtD
Pethidine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000156	0.00115	CcSEcCtD
Pethidine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000156	0.00114	CcSEcCtD
Pethidine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000156	0.00114	CcSEcCtD
Pethidine—Agitation—Ramipril—type 2 diabetes mellitus	0.000156	0.00114	CcSEcCtD
Pethidine—Constipation—Metformin—type 2 diabetes mellitus	0.000155	0.00114	CcSEcCtD
Pethidine—Anorexia—Losartan—type 2 diabetes mellitus	0.000154	0.00113	CcSEcCtD
Pethidine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000154	0.00112	CcSEcCtD
Pethidine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000153	0.00112	CcSEcCtD
Pethidine—Rash—Glyburide—type 2 diabetes mellitus	0.000152	0.00112	CcSEcCtD
Pethidine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000152	0.00112	CcSEcCtD
Pethidine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000152	0.00111	CcSEcCtD
Pethidine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000152	0.00111	CcSEcCtD
Pethidine—Syncope—Ramipril—type 2 diabetes mellitus	0.000152	0.00111	CcSEcCtD
Pethidine—Headache—Glyburide—type 2 diabetes mellitus	0.000151	0.00111	CcSEcCtD
Pethidine—Hypotension—Losartan—type 2 diabetes mellitus	0.000151	0.0011	CcSEcCtD
Pethidine—Palpitations—Ramipril—type 2 diabetes mellitus	0.00015	0.0011	CcSEcCtD
Pethidine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00015	0.0011	CcSEcCtD
Pethidine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000149	0.00109	CcSEcCtD
Pethidine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000149	0.00109	CcSEcCtD
Pethidine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000147	0.00108	CcSEcCtD
Pethidine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000147	0.00107	CcSEcCtD
Pethidine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000146	0.00107	CcSEcCtD
Pethidine—Insomnia—Losartan—type 2 diabetes mellitus	0.000146	0.00107	CcSEcCtD
Pethidine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000145	0.00106	CcSEcCtD
Pethidine—Urticaria—Metformin—type 2 diabetes mellitus	0.000144	0.00106	CcSEcCtD
Pethidine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000144	0.00105	CcSEcCtD
Pethidine—Nausea—Glyburide—type 2 diabetes mellitus	0.000144	0.00105	CcSEcCtD
Pethidine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Pethidine—Somnolence—Losartan—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Pethidine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Pethidine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000141	0.00103	CcSEcCtD
Pethidine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000141	0.00103	CcSEcCtD
Pethidine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000141	0.00103	CcSEcCtD
Pethidine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000141	0.00103	CcSEcCtD
Pethidine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00014	0.00103	CcSEcCtD
Pethidine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Pethidine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Pethidine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000138	0.00101	CcSEcCtD
Pethidine—Oedema—Ramipril—type 2 diabetes mellitus	0.000138	0.00101	CcSEcCtD
Pethidine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000138	0.00101	CcSEcCtD
Pethidine—Constipation—Losartan—type 2 diabetes mellitus	0.000138	0.00101	CcSEcCtD
Pethidine—Rash—Gliclazide—type 2 diabetes mellitus	0.000137	0.001	CcSEcCtD
Pethidine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000137	0.001	CcSEcCtD
Pethidine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000136	0.000996	CcSEcCtD
Pethidine—Shock—Ramipril—type 2 diabetes mellitus	0.000136	0.000996	CcSEcCtD
Pethidine—Headache—Gliclazide—type 2 diabetes mellitus	0.000136	0.000995	CcSEcCtD
Pethidine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000135	0.000988	CcSEcCtD
Pethidine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000134	0.000978	CcSEcCtD
Pethidine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000133	0.000973	CcSEcCtD
Pethidine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000132	0.000965	CcSEcCtD
Pethidine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000132	0.000965	CcSEcCtD
Pethidine—Dizziness—Orlistat—type 2 diabetes mellitus	0.00013	0.000954	CcSEcCtD
Pethidine—Asthenia—Metformin—type 2 diabetes mellitus	0.00013	0.000954	CcSEcCtD
Pethidine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000129	0.000946	CcSEcCtD
Pethidine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000129	0.000944	CcSEcCtD
Pethidine—Pruritus—Metformin—type 2 diabetes mellitus	0.000128	0.00094	CcSEcCtD
Pethidine—Urticaria—Losartan—type 2 diabetes mellitus	0.000128	0.000938	CcSEcCtD
Pethidine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000127	0.000928	CcSEcCtD
Pethidine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000126	0.000924	CcSEcCtD
Pethidine—Rash—Valsartan—type 2 diabetes mellitus	0.000126	0.00092	CcSEcCtD
Pethidine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000126	0.000919	CcSEcCtD
Pethidine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000125	0.000917	CcSEcCtD
Pethidine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000125	0.000915	CcSEcCtD
Pethidine—Headache—Valsartan—type 2 diabetes mellitus	0.000125	0.000914	CcSEcCtD
Pethidine—Rash—Orlistat—type 2 diabetes mellitus	0.000124	0.000909	CcSEcCtD
Pethidine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000124	0.000908	CcSEcCtD
Pethidine—CYP3A4—liver—type 2 diabetes mellitus	0.000124	0.00655	CbGeAlD
Pethidine—Headache—Orlistat—type 2 diabetes mellitus	0.000123	0.000903	CcSEcCtD
Pethidine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000123	0.0009	CcSEcCtD
Pethidine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000123	0.0009	CcSEcCtD
Pethidine—CYP2D6—liver—type 2 diabetes mellitus	0.000122	0.00644	CbGeAlD
Pethidine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000121	0.000887	CcSEcCtD
Pethidine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.00012	0.00088	CcSEcCtD
Pethidine—Dizziness—Metformin—type 2 diabetes mellitus	0.00012	0.000879	CcSEcCtD
Pethidine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000119	0.00087	CcSEcCtD
Pethidine—Nausea—Valsartan—type 2 diabetes mellitus	0.000118	0.000867	CcSEcCtD
Pethidine—Constipation—Ramipril—type 2 diabetes mellitus	0.000118	0.000866	CcSEcCtD
Pethidine—Nausea—Orlistat—type 2 diabetes mellitus	0.000117	0.000857	CcSEcCtD
Pethidine—Asthenia—Losartan—type 2 diabetes mellitus	0.000116	0.000847	CcSEcCtD
Pethidine—Vomiting—Metformin—type 2 diabetes mellitus	0.000115	0.000845	CcSEcCtD
Pethidine—Rash—Metformin—type 2 diabetes mellitus	0.000114	0.000838	CcSEcCtD
Pethidine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000114	0.000837	CcSEcCtD
Pethidine—Pruritus—Losartan—type 2 diabetes mellitus	0.000114	0.000835	CcSEcCtD
Pethidine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000114	0.000834	CcSEcCtD
Pethidine—Headache—Metformin—type 2 diabetes mellitus	0.000114	0.000833	CcSEcCtD
Pethidine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000113	0.000829	CcSEcCtD
Pethidine—Urticaria—Ramipril—type 2 diabetes mellitus	0.00011	0.000804	CcSEcCtD
Pethidine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000109	0.000797	CcSEcCtD
Pethidine—Rash—Irbesartan—type 2 diabetes mellitus	0.000108	0.000791	CcSEcCtD
Pethidine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000108	0.00079	CcSEcCtD
Pethidine—Nausea—Metformin—type 2 diabetes mellitus	0.000108	0.000789	CcSEcCtD
Pethidine—Headache—Irbesartan—type 2 diabetes mellitus	0.000107	0.000786	CcSEcCtD
Pethidine—Dizziness—Losartan—type 2 diabetes mellitus	0.000107	0.000781	CcSEcCtD
Pethidine—Vomiting—Losartan—type 2 diabetes mellitus	0.000102	0.000751	CcSEcCtD
Pethidine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000102	0.000746	CcSEcCtD
Pethidine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000102	0.000745	CcSEcCtD
Pethidine—Rash—Losartan—type 2 diabetes mellitus	0.000102	0.000744	CcSEcCtD
Pethidine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000102	0.000744	CcSEcCtD
Pethidine—Headache—Losartan—type 2 diabetes mellitus	0.000101	0.000739	CcSEcCtD
Pethidine—Asthenia—Ramipril—type 2 diabetes mellitus	9.92e-05	0.000726	CcSEcCtD
Pethidine—Pruritus—Ramipril—type 2 diabetes mellitus	9.78e-05	0.000716	CcSEcCtD
Pethidine—Nausea—Losartan—type 2 diabetes mellitus	9.58e-05	0.000701	CcSEcCtD
Pethidine—Dizziness—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000669	CcSEcCtD
Pethidine—Vomiting—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000644	CcSEcCtD
Pethidine—Rash—Ramipril—type 2 diabetes mellitus	8.72e-05	0.000638	CcSEcCtD
Pethidine—Dermatitis—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000638	CcSEcCtD
Pethidine—Headache—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000634	CcSEcCtD
Pethidine—Nausea—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000601	CcSEcCtD
Pethidine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	4.98e-06	4.69e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.96e-06	4.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.96e-06	4.67e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	4.95e-06	4.66e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	4.95e-06	4.66e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	4.95e-06	4.66e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	4.92e-06	4.64e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	4.92e-06	4.63e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.91e-06	4.62e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.89e-06	4.61e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.89e-06	4.61e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.87e-06	4.59e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	4.86e-06	4.58e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	4.86e-06	4.58e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.84e-06	4.56e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	4.84e-06	4.56e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	4.83e-06	4.55e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	4.83e-06	4.55e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	4.83e-06	4.55e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	4.83e-06	4.55e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.81e-06	4.53e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.79e-06	4.51e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.79e-06	4.51e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.79e-06	4.51e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.79e-06	4.51e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.79e-06	4.51e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	4.78e-06	4.5e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	4.77e-06	4.5e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.77e-06	4.5e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.76e-06	4.49e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	4.75e-06	4.48e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	4.74e-06	4.47e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.74e-06	4.46e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.73e-06	4.46e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.72e-06	4.45e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.7e-06	4.42e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	4.69e-06	4.42e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.68e-06	4.41e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.68e-06	4.41e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	4.66e-06	4.39e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GCG—type 2 diabetes mellitus	4.66e-06	4.39e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.66e-06	4.39e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.63e-06	4.36e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.6e-06	4.33e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	4.55e-06	4.29e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.52e-06	4.26e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.5e-06	4.24e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.45e-06	4.19e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.44e-06	4.18e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.44e-06	4.18e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.44e-06	4.18e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	4.43e-06	4.17e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.41e-06	4.16e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.37e-06	4.11e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.37e-06	4.11e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.36e-06	4.11e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	4.35e-06	4.1e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.32e-06	4.07e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.27e-06	4.03e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.26e-06	4.01e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	4.25e-06	4.01e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.25e-06	4e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.25e-06	4e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	4.24e-06	4e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.24e-06	3.99e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.23e-06	3.98e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.22e-06	3.97e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.19e-06	3.95e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.19e-06	3.94e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.19e-06	3.94e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	4.13e-06	3.89e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	4.09e-06	3.86e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.08e-06	3.85e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.08e-06	3.84e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.07e-06	3.84e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.07e-06	3.84e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.07e-06	3.84e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.07e-06	3.84e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.06e-06	3.83e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.03e-06	3.79e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.02e-06	3.79e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.02e-06	3.79e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.02e-06	3.78e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.02e-06	3.78e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4e-06	3.77e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	4e-06	3.77e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.96e-06	3.73e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.95e-06	3.73e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAT—type 2 diabetes mellitus	3.95e-06	3.72e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.94e-06	3.71e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.92e-06	3.69e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.91e-06	3.69e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.91e-06	3.68e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.85e-06	3.63e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.85e-06	3.63e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.84e-06	3.62e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOB—type 2 diabetes mellitus	3.83e-06	3.61e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.76e-06	3.54e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	3.75e-06	3.53e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	3.73e-06	3.51e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.72e-06	3.5e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.66e-06	3.45e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.66e-06	3.44e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.64e-06	3.43e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.64e-06	3.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.63e-06	3.42e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.61e-06	3.4e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.61e-06	3.4e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.6e-06	3.4e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	3.6e-06	3.39e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.59e-06	3.38e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.59e-06	3.38e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.59e-06	3.38e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.58e-06	3.38e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.58e-06	3.37e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.57e-06	3.36e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.54e-06	3.34e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.48e-06	3.28e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.44e-06	3.24e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.43e-06	3.23e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.41e-06	3.21e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.39e-06	3.19e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.38e-06	3.18e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.37e-06	3.18e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.35e-06	3.15e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.32e-06	3.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.32e-06	3.13e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.32e-06	3.13e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.32e-06	3.13e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.3e-06	3.11e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.3e-06	3.11e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.29e-06	3.1e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.28e-06	3.09e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.26e-06	3.07e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.26e-06	3.07e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.24e-06	3.05e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.24e-06	3.05e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.24e-06	3.05e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.23e-06	3.05e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.22e-06	3.03e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.22e-06	3.03e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.2e-06	3.02e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.17e-06	2.99e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.16e-06	2.98e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.16e-06	2.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.14e-06	2.96e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.13e-06	2.95e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.12e-06	2.94e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.12e-06	2.94e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.11e-06	2.93e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.08e-06	2.9e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.08e-06	2.9e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.08e-06	2.9e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.07e-06	2.9e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.07e-06	2.89e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.06e-06	2.88e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.05e-06	2.87e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.03e-06	2.86e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.03e-06	2.85e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.02e-06	2.85e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.96e-06	2.79e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.96e-06	2.79e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.95e-06	2.78e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.9e-06	2.74e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.9e-06	2.74e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.9e-06	2.74e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.9e-06	2.73e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.88e-06	2.71e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.87e-06	2.7e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.85e-06	2.69e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.85e-06	2.68e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.85e-06	2.68e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.83e-06	2.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.82e-06	2.66e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.81e-06	2.65e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.81e-06	2.65e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.79e-06	2.63e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.76e-06	2.6e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.76e-06	2.6e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.75e-06	2.59e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.75e-06	2.59e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.73e-06	2.57e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.73e-06	2.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.72e-06	2.56e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.72e-06	2.56e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.67e-06	2.52e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.67e-06	2.51e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.65e-06	2.5e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.65e-06	2.5e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.63e-06	2.47e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.63e-06	2.47e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—INS—type 2 diabetes mellitus	2.62e-06	2.47e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.6e-06	2.45e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.58e-06	2.44e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.58e-06	2.44e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.54e-06	2.39e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.53e-06	2.39e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.52e-06	2.37e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.52e-06	2.37e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.5e-06	2.36e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.5e-06	2.35e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.4e-06	2.26e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.37e-06	2.24e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.35e-06	2.22e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.33e-06	2.19e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-06	2.16e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-06	2.16e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.21e-06	2.08e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.17e-06	2.04e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.17e-06	2.04e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.16e-06	2.04e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.16e-06	2.03e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.16e-06	2.03e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.13e-06	2.01e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.12e-06	1.99e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.1e-06	1.98e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.07e-06	1.95e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.06e-06	1.94e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.06e-06	1.94e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.01e-06	1.9e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.98e-06	1.87e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.97e-06	1.86e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.95e-06	1.84e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.93e-06	1.82e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.93e-06	1.82e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.9e-06	1.79e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.9e-06	1.79e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.89e-06	1.78e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.88e-06	1.77e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.85e-06	1.75e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.79e-06	1.68e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.78e-06	1.68e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.74e-06	1.64e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.73e-06	1.63e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.69e-06	1.59e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.66e-06	1.57e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.66e-06	1.56e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.65e-06	1.55e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.64e-06	1.54e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.44e-06	1.36e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.41e-06	1.33e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.3e-06	1.22e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.25e-06	1.18e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.24e-06	1.17e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.24e-06	1.17e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-06	1.07e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	9.95e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.48e-07	8.93e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.72e-07	8.22e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.7e-07	5.37e-06	CbGpPWpGaD
